Antiviral medicine (for Hepatitis C)
Velakast ( SOFOSBUVIR 400MG & VELPATASVIR 100MG ) is a licensed generic drug used to treat hepatitis C. This product is an analogue of the American antiviral drug manufactured by Gilead Sciences, Inc. Monitoring compliance with production technology is carried out by American employees of Gilead Corporation and Russian specialists. A feature of Velakast is the combination of sofosbuvir and velpatasvir. Studies confirm that this combination is 10% more effective than taking sofosbuvir with daclatasvir or ledipasvir. In addition, it is third-generation drugs that contribute to the cure of a patient from the virus of 2 or 3 genotypes without the appointment of ribavirin.